Cortical development in the presenilin-1 null mutant mouse fails after splitting of the preplate and is not due to a failure of reelin-dependent signaling

Developmental Dynamics

Volumn 237, Issue 9, 2008, Pages 2405-2414

  De Gasperi, Rita ^a,b   Gama Sosa, Miguel A ^a,b   Wen, Paul H ^a,b   Li, Jingjun ^b   Perez, Gissel M ^a,b   Curran, Tom ^c   Elder, Gregory A ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Cortical lamination; Gamma secretase; Presenilin 1; Reelin

Indexed keywords

ADAPTOR PROTEIN; GAMMA SECRETASE; PRESENILIN 1; PROTEIN DAB1; REELIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; MOUSE; MUTANT; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TELENCEPHALON; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BLOTTING, WESTERN; CELL ADHESION MOLECULES, NEURONAL; CELL LINE; CELLS, CULTURED; CEREBRAL CORTEX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PRESENILIN-1; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION;

MUS;

EID: 51549086925     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21661     Document Type: Article

References (58)

1. Ayala R, Shu T, Tsai LH. 2007. Trekking across the brain: the journey of neuronal migration. Cell 128:29-43.
2. Baki L, Shioi J, Wen P, Shao Z, Schwarzman A, Gama-Sosa M, Neve R, Robakis NK. 2004. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J 23:2586-2596.
3. Beffert U, Morfini G, Bock HH, Reyna H, Brady ST, Herz J. 2002. Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J Biol Chem 277:49958-49964.
4. Bicknese AR, Sheppard AM, O'Leary DD, Pearlman AL. 1994. Thalamocortical axons extend along a chondroitin sulfate proteoglycan-enriched pathway coincident with the neocortical subplate and distinct from the efferent path. J Neurosci 14:3500-3510.
5. Bock HH, Jossin Y, Liu P, Forster E, May P, Goffinet AM, Herz J. 2003. Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J Biol Chem 278:38772-38779.
6. D'Arcangelo G. 2006. Reelin mouse mutants as models of cortical development disorders. Epilepsy Behav 8:81-90.
7. D'Arcangelo G, Nakajima K, Miyata T, Ogawa M, Mikoshiba K, Curran T. 1997. Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody. J Neurosci 17:23-31.
8. De Sarno P, Lesort M, Bijur GN, Johnson GV, Jope RS. 2001. Cholinergic- and stress-induced signaling activities in cells overexpressing wild-type and mutant presenilin-1. Brain Res 903:226-230.
9. Fonseca M, del Rio JA, Martinez A, Gomez S, Soriano E. 1995. Development of calretinin immunoreactivity in the neocortex of the rat. J Comp Neurol 361:177-192.
10. Gama Sosa MA, De Gasperi R, Rocher AB, Perez GM, Simons K, Cruz DE, Hof PR, Elder GA. 2007. Interactions of primary neuroepithelial progenitor and brain endothelial cells: distinct effect on neural progenitor maintenance and differentiation by soluble factors and direct contact. Cell Res 17:619-626.
11. Gilmore EC, Ohshima T, Goffinet AM, Kulkarni AB, Herrup K. 1998. Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J Neurosci 18:6370-6377.
12. Gupta A, Tsai LH, Wynshaw-Boris A. 2002. Life is a journey: a genetic look at neocortical development. Nat Rev Genet 3:342-355.
13. Handler M, Yang X, Shen J. 2000. Presenilin-1 regulates neuronal differentiation during neurogenesis. Development 127:2593-2606.
14. Hartmann D, De Strooper B, Saftig P. 1999. Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly. Curr Biol 9:719-727.
15. Herz J, Chen Y. 2006. Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev Neurosci 7:850-859.
16. Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, Herz J. 1999. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24:481-489.
17. Hoe HS, Rebeck GW. 2005. Regulation of ApoE receptor proteolysis by ligand binding. Mol Brain Res 137:31-39.
18. Howell BW, Hawkes R, Soriano P, Cooper JA. 1997. Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 389:733-737.
19. Iwatsubo T. 2004. The gamma-secretase complex: machinery for intramembrane proteolysis. Curr Opin Neurobiol 14:379-383.
20. Kang DE, Yoon IS, Repetto E, Busse T, Yermian N, Ie L, Koo EH. 2005. Presenilins mediate phosphatidylinositol 3-kinase/AKT and ERK activation via select signaling receptors. Selectivity of PS2 in platelet-derived growth factor signaling. J Biol Chem 280:31537-31547.
21. Kesavapany S, Lau KF, McLoughlin DM, Brownlees J, Ackerley S, Leigh PN, Shaw CE, Miller CC. 2001. p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction. Eur J Neurosci 13:241-247.
22. Keshvara L, Magdaleno S, Benhayon D, Curran T. 2002. Cyclin-dependent kinase 5 phosphorylates disabled 1 independently of Reelin signaling. J Neurosci 22:4869-4877.
23. Kilb W, Hartmann D, Saftig P, Luhmann HJ. 2004. Altered morphological and electrophysiological properties of Cajal-Retzius cells in cerebral cortex of embryonic Presenilin-1 knockout mice. Eur J Neurosci 20:2749-2756.
24. Kim WY, Shen J. 2008. Presenilins are required for maintenance of neural stem cells in the developing brain. Mol Neurodegener 3:2.
25. Kinoshita A, Shah T, Tangredi MM, Strickland DK, Hyman BT. 2003. The intracellular domain of the low density lipoprotein receptor-related protein modulates transactivation mediated by amyloid precursor protein and Fe65. J Biol Chem 278:41182-41188.
26. Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH. 2001. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21:6758-6771.
27. Kwon YT, Tsai LH. 1998. A novel disruption of cortical development in p35(-/-) mice distinct from reeler. J Comp Neurol 395:510-522.
28. Lai EC. 2004. Notch signaling: control of cell communication and cell fate. Development 131:965-973.
29. Lau KF, Howlett DR, Kesavapany S, Standen CL, Dingwall C, McLoughlin DM, Miller CC. 2002. Cyclin-dependent kinase-5/p35 phosphorylates Presenilin 1 to regulate carboxy-terminal fragment stability. Mol Cell Neurosci 20:13-20.
30. Louvi A, Sisodia SS, Grove EA. 2004. Presenilin 1 in migration and morphogenesis in the central nervous system. Development 131:3093-3105.
31. Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, Baki L, Wen P, Efthimiopoulos S, Shao Z, Wisniewski T, Robakis NK. 2002. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 21:1948-1956.
32. May P, Reddy YK, Herz J. 2002. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J Biol Chem 277:18736-18743.
33. May P, Bock HH, Nimpf J, Herz J. 2003. Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. J Biol Chem 278:37386-37392.
34. Nakajima M, Moriizumi E, Koseki H, Shirasawa T. 2004. Presenilin 1 is essential for cardiac morphogenesis. Dev Dyn 230:795-799.
35. Raychaudhuri M, Mukhopadhyay D. 2007. AICD and its adaptors - in search of new players. J Alzheimers Dis 11:343-358.
36. Repetto E, Yoon IS, Zheng H, Kang DE. 2007. Presenilin 1 regulates epidermal growth factor receptor turnover and signaling in the endosomal-lysosomal pathway. J Biol Chem 282:31504-31516.
37. Rice D, Curran T. 2001. Role of reelin signaling pathway in central nervous system development. Annu Rev Neurosci 24:1005-1039.
38. Rice DS, Sheldon M, D'Arcangelo G, Nakajima K, Goldowitz D, Curran T. 1998. Disabled-1 acts downstream of Reelin in a signaling pathway that controls laminar organization in the mammalian brain. Development 125:3719-3729.
39. Sardi SP, Murtie J, Koirala S, Patten BA, Corfas G. 2006. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 127:185-197.
40. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. 1997. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89:629-639.
41. Sheppard AM, Pearlman AL. 1997. Abnormal reorganization of preplate neurons and their associated extracellular matrix: an early manifestation of altered neocortical development in the reeler mutant mouse. J Comp Neurol 378:173-179.
42. Sheppard AM, Hamilton SK, Pearlman AL. 1991. Changes in the distribution of extracellular matrix components accompany early morphogenetic events of mammalian cortical development. J Neurosci 11:3928-3942.
43. St George-Hyslop PH. 2000. Molecular genetics of Alzheimer's disease. Biol Psychiatry 47:183-199.
44. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, Hammer RE, Richardson JA, Herz J. 1999. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97:689-701.
45. Tsai LH, Takahashi T, Caviness VS, Jr., Harlow E. 1993. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119:1029-1040.
46. Vestling M, Wiehager B, Tanii H, Cowburn RF. 2001. Akt activity in presenilin 1 wild-type and mutation transfected human SH-SY5Y neuroblastoma cells after serum deprivation and high glucose stress. J Neurosci Res 66:448-456.
47. Vetrivel KS, Zhang YW, Xu H, Thinakaran G. 2006. Pathological and physiological functions of presenilins. Mol Neurodegener 1:4.
48. Weihl CC, Ghadge GD, Kennedy SG, Hay N, Miller RJ, Roos RP. 1999. Mutant presenilin-1 induces apoptosis and down-regulates Akt/PKB. J Neurosci 19:5360-5369.
49. Weisenhorn DM, Prieto EW, Celio MR. 1994. Localization of calretinin in cells of layer I (Cajal-Retzius cells) of the developing cortex of the rat. Dev Brain Res 82:293-297.
50. Wen PH, Shao X, Shao Z, Hof PR, Wisniewski T, Kelley K, Friedrich VL, Jr., Ho L, Pasinetti GM, Shioi J, Robakis NK, Elder GA. 2002. Overexpression of wild-type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice. Neurobiol Dis 10:8-19.
51. Wen PH, De Gasperi R, Gama Sosa MA, Elder GA. 2004. Neural progenitor cells do not differentiate prematurely in presenilin-1 null mutant mice. Neurosci Lett 371:249-254.
52. Wen PH, De Gasperi R, Sosa MA, Rocher AB, Friedrich VL, Jr., Hof PR, Elder GA. 2005. Selective expression of presenilin 1 in neural progenitor cells rescues the cerebral hemorrhages and cortical lamination defects in presenilin 1-null mutant mice. Development 132:3873-3883.
53. Wines-Samuelson M, Handler M, Shen J. 2005. Role of presenilin-1 in cortical lamination and survival of Cajal-Retzius neurons. Dev Biol 277:332-346.
54. Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ, Trumbauer ME, Chen HY, Price DL, Van der Ploeg LH, Sisodia SS. 1997. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387:288-292.
55. Yoshida M, Assimacopoulos S, Jones KR, Grove EA. 2006. Massive loss of Cajal-Retzius cells does not disrupt neocortical layer order. Development 133:537-545.
56. Yuasa S, Nakajima M, Aizawa H, Sahara N, Koizumi K, Sakai T, Usami M, Kobayashi S, Kuroyanagi H, Mori H, Koseki H, Shirasawa T. 2002. Impaired cell cycle control of neuronal precursor cells in the neocortical primordium of presenilin-1-deficient mice. J Neurosci Res 70: 501-513.
57. Zhang H, Liu R, Wang R, Hong S, Xu H, Zhang YW. 2007. Presenilins regulate the cellular level of the tumor suppressor PTEN. Neurobiol Aging 29:653-660.
58. Zheng M, Leung CL, Liem RK. 1998. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. J Neurobiol 35:141-159.